Lemaitre Vascular (LMAT) Capital Expenditures (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Capital Expenditures of $2.8 million for Q1 2026, up 101.23% year-over-year from $1.4 million in Q1 2025, and up 56.61% quarter-over-quarter from $1.8 million in Q4 2025.
Lemaitre Vascular (LMAT) Capital Expenditures (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Capital Expenditures for 17 consecutive years, with $2.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures rose 101.23% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $8.2 million (up 17.32% YoY), while the FY2025 annual figure was $6.8 million, down 2.57% from the prior year.
- Capital Expenditures advanced to $2.8 million in Q1 2026 per LMAT's latest filing, from $1.8 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $2.8 million in Q2 2023 and bottomed at $460000.0 in Q3 2022.
- Historically, Capital Expenditures has averaged $1.6 million across 5 years, with a median of $1.4 million in 2025.
- Annual changes were most pronounced in 2022 — Capital Expenditures plunged 74.64% — and 2023, when it soared 297.39%.
- Lemaitre Vascular's Capital Expenditures stood at $1.3 million in 2022, then rose by 1.51% to $1.3 million in 2023, then surged by 59.81% to $2.0 million in 2024, then dropped by 13.06% to $1.8 million in 2025, then jumped by 56.61% to $2.8 million in 2026.
- Business Quant data shows LMAT's Capital Expenditures at $2.8 million in Q1 2026, $1.8 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 135.00 Bn | 129.79 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.50 Bn | 51.64 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.74 Bn | 34.39 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.91 Bn | 32.44 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.11 Bn | 26.44 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 24.88 Bn | 24.44 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.34 Bn | 14.94 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Lemaitre Vascular | 1.89 Bn | 1.51 Bn | 50.76 Mn | 2.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.31 Mn |
| Jun 30, 2026 | 2.31 Mn |
| Mar 31, 2026 | 2.78 Mn |
| Mar 31, 2026 | 2.78 Mn |
| Dec 31, 2025 | 1.78 Mn |
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.37 Mn |